Results 151 to 160 of about 389,483 (184)

Vitreomacular adhesion in exudative age macular degeneration

Acta Ophthalmologica, 2010
Abstract Purpose To evaluate posterior vitreomacular adhesion in exudative age‐related macular degeneration (AMD) using Stratus optical coherence tomography (OCT). Methods Retrospective observational consecutive case series about 50 eyes of 50 patients (age 57‐91 years) treated for choroidal neovacularisation (CNV) and examined with ( OCT ...
JP BERROD, G HAOUACHE, I HUBERT
openaire   +1 more source

Vitreomacular Adhesion/Traction Syndromes

2016
Vitreomacular adhesion and traction syndromes are diseases involving pathologic interaction of the vitreoretinal interface. These diseases have been greater delineated with the advent of spectral domain OCT, which has allowed for precise imaging leading to greater description and understanding of the various disease processes. This chapter demonstrates
openaire   +1 more source

Ocriplasmin: A Review of Its Use in Patients with Symptomatic Vitreomacular Adhesion

Drugs, 2013
Ocriplasmin (JETREA(®)) is a recombinant human serine protease plasmin with proteolytic activity against the protein components (e.g. laminin, fibronectin and collagen) of the vitreous and vitreoretinal interface, thereby facilitating vitreous liquefaction and separation of vitreous from the retina.
Yahiya Y, Syed, Sohita, Dhillon
openaire   +2 more sources

Intravitreal tissue plasminogen activator for treatment of vitreomacular adhesion

International Eye Research, 2020
AIM: To evaluate the role of a single intravitreal injection of tissue plasminogen activator alone (TPA) for treatment of vitreomacular traction and the effect of combined intravitreal TPA and bevacizumab on retinal vascular diseases. METHODS: In this prospective, interventional case series a total of 24 eyes from 24 patients were studied. There were 5
Saeed Karimi, Homayoun Nikkhah, Azadeh Haseli Mofrad   +2 more
openaire   +1 more source

Vitreomacular observations. I. Vitreomacular adhesion and hole in the premacular hyaloid.

Ophthalmology, 1994
Variations in vitreomacular adhesions and the significance of a hole in the premacular hyaloid membrane were studied clinically to better understand vitreomacular pathology.With an El-Bayadi-Kajiura aspheric preset lens, the authors used a vitreous examination technique on 96 eyes, which were divided into three groups.
A, Kakehashi, C L, Schepens, C L, Trempe
openaire   +1 more source

Detecting vitreomacular adhesions in eyes with asteroid hyalosis with triamcinolone acetonide

Graefe's Archive for Clinical and Experimental Ophthalmology, 2006
To report the incidence of posterior vitreous detachments (PVDs) and the surgical results of vitrectomy with intravitreal triamcinolone acetonide (TA) to detect vitreomacular adhesions in eyes with asteroid hyalosis (AH).Ten eyes of nine patients with AH underwent vitrectomy, six eyes with TA and four without TA.
Takefumi, Yamaguchi, Makoto, Inoue, Susumu, Ishida, Kei, Shinoda   +3 more
openaire   +2 more sources

[Classification of vitreomacular adhesion and macular holes].

Journal francais d'ophtalmologie, 2016
Optical coherence tomography has significantly changed the approach to vitreomacular diseases, including macular holes (MH). OCT provides information on differential diagnoses (lamellar hole, pseudo-hole), the MH size, the status of the vitreous, and the status of the various retinal layers. The evolution of diagnostic tools and treatment justifies the
Y, Le Mer, J-F, Korobelnik, L, Kodjikian, C, Creuzot-Garcher, M, Weber, F, Devin, J-C, Zech, S Y, Cohen, R, Tadayoni   +8 more
openaire   +1 more source

Ocriplasmin: a guide to its use in symptomatic vitreomacular adhesion

Drugs & Therapy Perspectives, 2014
Ocriplasmin (Jetrea®) is a stable, recombinant, truncated form of human serine protease plasmin that has proteolytic activity against the protein components of the vitreous and vitreoretinal interface, thereby facilitating vitreous liquefaction and separation of vitreous from the retina.
Gillian M. Keating, Yahiya Y. Syed, Sohita Dhillon   +2 more
openaire   +1 more source

SAFETY PROFILE OF OCRIPLASMIN FOR THE PHARMACOLOGIC TREATMENT OF SYMPTOMATIC VITREOMACULAR ADHESION/TRACTION

Retina, 2015
To report the safety of intravitreal ocriplasmin injection based on 2 Phase 3 clinical trials in patients with symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with full-thickness macular holes.Safety analyses were based on 2 completed Phase 3 studies assessing intravitreal ocriplasmin injection. Adverse events (AEs),
Kaiser, Peter K., Kampik, Anselm, Kuppermann, Baruch D., Girach, Aniz, RIZZO, STANISLAO, Sergott, Robert C.   +5 more
openaire   +2 more sources

SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION

Retina, 2015
After the recent approval of ocriplasmin by the Food and Drug Administration, postmarketing safety concerns have been raised by the vitreoretinal community. The American Society of Retina Specialists Therapeutic Surveillance Committee was commissioned to monitor postmarketing drug-related and device-related adverse events. The purpose of this report is
Paul, Hahn, Mina M, Chung, Harry W, Flynn, Suber S, Huang, Judy E, Kim, Tamer H, Mahmoud, Srinivas R, Sadda, Pravin U, Dugel   +7 more
openaire   +2 more sources